We are proud to announce the successful completion of 24-months of follow-up for the IMAGE trial, a landmark study evaluating the role of Melanoma Surveillance Photography (MSP) in improving early detection of melanoma among high and ultra-high-risk patients. This milestone marks a significant step in assessing the long-term impact of MSP on reducing unnecessary biopsies and improving diagnostic accuracy.
“The IMAGE trial addresses a critical evidence gap for the use of total body photography in surveillance of people with melanoma and…